Liisa Porra

University of Helsinki

Papers

1

Total Citations

18

H-Index

1

About

Liisa Porra is a leading figure in the advancement of boron neutron capture therapy (BNCT), a targeted form of radiation oncology. Her primary research focuses on the clinical translation and optimization of BNCT, particularly for treating aggressive cancers. Porra’s major contribution is her comprehensive analysis of the Finnish BNCT experience, where she reviewed outcomes for 249 patients treated at Helsinki University Hospital between 1999 and 2012. This pivotal work, cited 18 times, documents the transition from nuclear reactor-based neutron sources to modern proton accelerator-based systems, demonstrating the therapy’s safety and efficacy. Her research has been instrumental in establishing BNCT as a viable clinical option, especially for head and neck cancers and glioblastoma. Beyond her clinical studies, Porra has contributed to dosimetry and treatment planning protocols that enhance precision. Her work has shaped the global BNCT community, influencing the design of next-generation facilities. A respected collaborator, Porra continues to drive innovation in particle therapy, bridging historical reactor-based treatments with cutting-edge accelerator technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience
18 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Helsinki

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago